News from the FDA/CDC

FDA issues public health warning recommending against cesium salt usage


 

The Food and Drug Administration has issued a public health alert warning consumers to avoid the use of dietary supplements that contain cesium chloride or any other cesium salt because of significant safety risks.

FDA icon

Cesium salts are sometimes advertised as an alternative treatment for cancer, the FDA said in the announcement, but these salts have never proved to be safe or effective at treating cancer or any other disease. Clinical case reports and nonclinical trials have shown that cesium salts are associated with a variety of adverse events, including cardiac arrhythmias, hypokalemia, seizures, syncope, and death.

The FDA warned health care providers that cesium salts presented a significant safety risk in compounding drugs in July 2018.

Health care providers should not recommend dietary supplements containing cesium salts to their patients, the FDA said, and if a patient experiences an adverse event while taking a supplement containing cesium salt, the event should be reported to the agency.

While there are few dietary supplements on the market that contain cesium salt, consumers should be aware of the risks and avoid these products. The FDA noted that “if claims sound too good to be true, they probably are.”

Recommended Reading

U.S. deaths from preventable causes occur more often in rural areas
MDedge Hematology and Oncology
GALILEO, GALILEO 4D: Mixed results in post-TAVR anticoagulation
MDedge Hematology and Oncology
Aspirin plus a DOAC may do more harm than good in some
MDedge Hematology and Oncology
New ASH guideline: VTE prophylaxis after major surgery
MDedge Hematology and Oncology
ASH releases guidelines on managing cardiopulmonary and kidney disease in SCD
MDedge Hematology and Oncology
Are providers asking about menstrual bleeding before/during anticoagulant therapy?
MDedge Hematology and Oncology
Adult survivors of childhood cancer are experiencing fewer major cardiac events
MDedge Hematology and Oncology
Carbs, fat, and mortality: Types matter more than levels
MDedge Hematology and Oncology
FDA: Cybersecurity vulnerabilities identified in GE Healthcare monitoring devices
MDedge Hematology and Oncology
Walk test may predict complications after lung cancer surgery
MDedge Hematology and Oncology